X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
humans (8) 8
multiple myeloma (6) 6
female (5) 5
hematology, oncology and palliative medicine (5) 5
male (5) 5
multiple myeloma - drug therapy (5) 5
aged (4) 4
analysis (4) 4
disease-free survival (4) 4
middle aged (4) 4
oncology (4) 4
adult (3) 3
animals (3) 3
bortezomib (3) 3
care and treatment (3) 3
drug therapy (3) 3
hematology (3) 3
history (3) 3
lymphomas (3) 3
protein structure, tertiary (3) 3
stem cells (3) 3
survival (3) 3
therapy (3) 3
transplantation (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
amino acid sequence (2) 2
anemia (2) 2
angiogenesis inhibitors (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biochemistry & molecular biology (2) 2
biopsy (2) 2
bone marrow (2) 2
cell biology (2) 2
chemotherapy (2) 2
clinical trials (2) 2
consensus (2) 2
cytotoxicity (2) 2
dexamethasone (2) 2
drosophila (2) 2
drosophila proteins - chemistry (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
ecdysteroid receptor (2) 2
germany relations (2) 2
hemic and lymphatic diseases (2) 2
internal medicine (2) 2
intravenous administration (2) 2
medical colleges (2) 2
medicine, general & internal (2) 2
molecular sequence data (2) 2
neoplasm recurrence, local - drug therapy (2) 2
poland relations (2) 2
poland relations germany (2) 2
product development (2) 2
proteins (2) 2
relations (2) 2
stem cell transplantation (2) 2
studies (2) 2
survival rate (2) 2
thalidomide - analogs & derivatives (2) 2
transplants & implants (2) 2
urine (2) 2
20-hydroxyecdysone (1) 1
activation (1) 1
active transport, cell nucleus - drug effects (1) 1
active-site (1) 1
advanced-stage (1) 1
aerial insects (1) 1
aerially foraging vertebrates (1) 1
aerials (1) 1
aged, 80 and over (1) 1
agricultural landscapes (1) 1
amino acid substitution (1) 1
anemia - chemically induced (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antiviral responses (1) 1
arm clinical-trials (1) 1
article (1) 1
aryl-hydrocarbon receptor (1) 1
asthma (1) 1
authentisierung (1) 1
autografts (1) 1
barn swallows (1) 1
basic helix-loop-helix transcription factors - chemistry (1) 1
basic helix-loop-helix transcription factors - metabolism (1) 1
bhlh-pas transcription factor (1) 1
binding sites (1) 1
biography (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. 1311 - 1318
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2017, Volume 18, Issue 4, pp. e206 - e217
The International Myeloma Working Group consensus aimed to provide recommendations for the optimal use of fluorodeoxyglucose ( F-FDG) PET/CT in patients with... 
Journal Article
2003, Originalausg., Beck'sche Reihe, ISBN 9783406494369, Volume 1517, 631
Book
Cell Reports, ISSN 2211-1247, 12/2019, Volume 29, Issue 11, pp. 3460 - 3471.e7
Microglia express Toll-like receptors (TLRs) that sense pathogen- and host-derived factors, including single-stranded RNA. In the brain, microRNA (miRNA)... 
microRNA | Toll-like receptor 7 | glioblastoma | microglia | lethal-7 | STEM-CELLS | ANTIVIRAL RESPONSES | ACTIVATION | INTERCELLULAR-ADHESION MOLECULE-1 | RNA | RECOGNITION | IMMUNE-RESPONSES | INNATE | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | CELL BIOLOGY
Journal Article